The lipodystrophy syndrome is a newly recognized syndrome among HIV-infected men and women. The investigator has shown in a recent collaboration with the Framingham Heart Study that patients with lipodystrophy demonstrate a significant insulin resistance syndrome , characterized by hyperinsulinemia, dyslipidemia and increased diastolic blood pressure. Insulin resistance associated with the HIV lipodystrophy syndrome poses a considerable risk for long-term increased cardiovascular disease, but little is known of its mechanism nor has treatment been established. Fat redistribution is strikingly abnormal in affected female patients, but the gender-specific cardiovascular consequences of the insulin resistant phenotype are not known. In this grant proposal this project will determine the gender-specific characteristics of the insulin resistant phenotype in HIV-infected men and women. The investigator will test the hypothesis that truncal fat gain and subcutaneous fat loss contribute independently to the insulin resistant phenotype, and furthermore, that hyperinsulinemia impairs fibrinolysis and disrupts endothelial function leading to increased carotid intimal medial thickness and stenosis. The investigator will test the hypothesis that increased circulating free fatty acids (FFA) resulting from fat redistribution contribute to insulin resistance and increased endogenous hepatic glucose production. Simultaneously, a novel approach to the treatment of insulin resistance in patients with the lipodystrophy syndrome, in which there was shown an effect of metformin to lower insulin levels in preliminary studies. In the final aim of the proposal, the project will investigate in vitro, the independent and combined effects of PI's and nucleoside analogues on human subcutaneous and visceral adipocytes. These studies will allow us to determine for the first time the depot-specific mechanisms by which these agents may lead to subcutaneous fat loss and visceral fat gain and thereby promote insulin resistance. This project will study the effects of these agent on adipogensis, differentiation, insulin sensitivity and expression of PPAR and other adipocyte regulatory genes using thiazolidinediones to determine whether PPAR gamma activation can rescue the differentiated phenotype. The novel studies in this grant proposal will provide important new information on mechanisms, cardiovascular effects and optimal treatments for insulin resistance in the HIV-lipodystrophy syndrome. The proposed studies represent a significant collaborative effort between clinical researchers, adipocyte biologists, epidemiologists and nutritional biochemists in satisfaction of the mandate of the RFA.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK059535-03
Application #
6524494
Study Section
Special Emphasis Panel (ZHL1-CSR-A (M2))
Program Officer
Teff, Karen L
Project Start
2000-09-15
Project End
2005-08-31
Budget Start
2002-09-01
Budget End
2003-08-31
Support Year
3
Fiscal Year
2002
Total Cost
$427,452
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Raboud, Janet M; Diong, Christina; Carr, Andrew et al. (2010) A meta-analysis of six placebo-controlled trials of thiazolidinedione therapy for HIV lipoatrophy. HIV Clin Trials 11:39-50
Lo, Janet; Looby, Sara E D; Wei, Jeffrey et al. (2009) Increased aldosterone among HIV-infected women with visceral fat accumulation. AIDS 23:2366-70
Hadigan, Colleen; Mazza, Sasha; Crum, Dana et al. (2007) Rosiglitazone increases small dense low-density lipoprotein concentration and decreases high-density lipoprotein particle size in HIV-infected patients. AIDS 21:2543-6
Triant, Virginia A; Lee, Hang; Hadigan, Colleen et al. (2007) Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab 92:2506-12
Dolan, Sara E; Carpenter, Sara; Grinspoon, Steven (2007) Effects of weight, body composition, and testosterone on bone mineral density in HIV-infected women. J Acquir Immune Defic Syndr 45:161-7
Fleischman, Amy; Johnsen, Stine; Systrom, David M et al. (2007) Effects of a nucleoside reverse transcriptase inhibitor, stavudine, on glucose disposal and mitochondrial function in muscle of healthy adults. Am J Physiol Endocrinol Metab 292:E1666-73
Hadigan, Colleen; Liebau, James; Torriani, Martin et al. (2006) Improved triglycerides and insulin sensitivity with 3 months of acipimox in human immunodeficiency virus-infected patients with hypertriglyceridemia. J Clin Endocrinol Metab 91:4438-44
Sankale, J-L G; Tong, Q; Hadigan, C M et al. (2006) Regulation of adiponectin in adipocytes upon exposure to HIV-1. HIV Med 7:268-74
Johnsen, Stine; Dolan, Sara E; Fitch, Kathleen V et al. (2006) Carotid intimal medial thickness in human immunodeficiency virus-infected women: effects of protease inhibitor use, cardiac risk factors, and the metabolic syndrome. J Clin Endocrinol Metab 91:4916-24
Lo, Janet; Dolan, Sara E; Kanter, Jenna R et al. (2006) Effects of obesity, body composition, and adiponectin on carotid intima-media thickness in healthy women. J Clin Endocrinol Metab 91:1677-82

Showing the most recent 10 out of 32 publications